Entero Therapeutics enters up to $5M securities purchase agreement with initial $500k closing

GridAI Technologies Corp.

Initial closing of $500k non-interest bearing promissory note due one year and one day from issuance.
Warrants to purchase up to 1.52M shares at $2.50/share, exercisable after stockholder approval.
Company may hold subsequent closings for remaining $4.5M through Final Closing Date.
Proceeds for general corporate purposes, including working capital and potential acquisitions.
Note is not convertible; maturity may be extended in one-year increments.

item 1.01 item 2.03 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001104659-25-101519
form_type: 8-K
ticker: GRDX
cik: 0001604191
company_name: GridAI Technologies Corp.
filed_at: 2025-10-22T23:59:59+00:00
discovered_at: 2026-05-14T18:02:39.895538+00:00
generated_at: 2026-05-17T02:45:31.074620+00:00
sec_items: ["1.01", "2.03", "9.01"]
event_type: debt
sentiment: neutral
materiality_score: 0.7
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001104659-25-101519
json_url: https://secwatch.observer/filing/0001104659-25-101519.json
markdown_url: https://secwatch.observer/filing/0001104659-25-101519.md
text_url: https://secwatch.observer/filing/0001104659-25-101519.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1604191/000110465925101519/0001104659-25-101519-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1604191/000110465925101519/tm2529176d1_8k.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Source: SEC EDGAR

accession 0001104659-25-101519

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.